PSX · PHARMACEUTICALS
IBLHL IBL HealthCare
IBLHL closed at Rs 40.28 on 20 Oct 2026: −1.92% on the day, −18.5% over one year.
Open the chart
IBLHL technical readings
From daily closes to , close Rs 40.28. Measurements, not advice.
- 14-day RSI: 36.3 on a 0–100 scale
- 50-day average close: Rs 44.31 · the close is 9.1% below it
- 200-day average close: Rs 49.25 · the close is 18.2% below it
- 52-week range: Rs 36.00 – Rs 85.82 · the close is 9% of the way up
IBLHL monthly closes
Last close of each month, to .
- Nov 2025 Rs 57.36 +22.8%
- Dec 2025 Rs 63.95 +11.5%
- Jan 2026 Rs 57.85 −9.5%
- Feb 2026 Rs 43.37 −25.0%
- Mar 2026 Rs 39.12 −9.8%
- Apr 2026 Rs 45.48 +16.3%
- May 2026 Rs 46.24 +1.7%
- Jun 2026 Rs 53.02 +14.7%
- Jul 2026 Rs 48.96 −7.7%
- Aug 2026 Rs 46.52 −5.0%
- Sep 2026 Rs 42.64 −8.3%
- Oct 2026 Rs 40.28 −5.5%
Recent explained moves
- −3.34%
Down 3.3% on 1.3× the usual volume. The pharmaceuticals sector moved the same way, median -1.3% (12 of 14 names down). The KSE-100 moved -1.0% the same day. Financial results were announced within the last two sessions. - +3.62%
Up 3.6% on 1.5× the usual volume, gapping 2.5% at the open. No filing, sector move or volume behind it in the data. - +3.90%
Up 3.9% on 1.5× the usual volume. The pharmaceuticals sector moved the same way, median +1.7% (13 of 14 names up). The KSE-100 moved +1.1% the same day. - −3.15%
Down 3.2% on 1.1× the usual volume. Foreign investors were net sellers of Rs 1,786M across the market. No filing, sector move or volume behind it in the data. - +7.24%
Up 7.2% on 0.5× the usual volume, gapping 2.7% at the open. The pharmaceuticals sector moved the same way, median +3.2% (13 of 14 names up). The KSE-100 moved +4.2% the same day. Foreign investors were net sellers of Rs 1,059M across the market. A board meeting was notified within the last two sessions.